Treating T-cell lymphoma: is there a light at the end of the tunnel?
- First Online:
- Cite this article as:
- Hopfinger, G., Merkel, O., Melchardt, T. et al. memo (2012) 5: 174. doi:10.1007/s12254-012-0013-4
- 62 Downloads
Treating peripheral T-cell lymphomas (PTCL) remains a clinical challenge harbouring an often aggressive course and furthermore, no standard therapy is established. In more detail, PTCL comprises a heterogeneous group of haematological tumours constituting less than 15 % of all non-Hodgkin’s lymphomas (NHLs) in adults in the western hemisphere. The following short review will provide an up-date based on data presented at ASH meeting 2011 in PTCL providing improved understanding of patho-mechanism and further development of more specific therapy options.